Comerica (CMA) Form 144 Files Proposed Sale of 4,000 Shares
Rhea-AI Filing Summary
Comerica Incorporated reports a proposed insider sale of 4,000 common shares through Fidelity Brokerage Services LLC on the NYSE with an approximate sale date of 08/08/2025. The filing lists an aggregate market value of $269,140 and shows 128,525,470 shares outstanding, indicating the sale represents a very small fraction of total equity.
The shares were acquired as restricted stock vesting on 01/26/2023 (1,274 shares) and 02/28/2023 (2,726 shares) and were paid as compensation. The filer reports "Nothing to Report" for securities sold in the past three months and affirms no undisclosed material adverse information.
Positive
- Complete disclosure of broker, acquisition dates, and payment nature (compensation)
- Small transaction size relative to total outstanding shares (4,000 vs 128,525,470), limiting market impact
Negative
- None.
Insights
TL;DR: Routine small insider sale; immaterial to capitalization but important for transparency.
The filing discloses a proposed sale of 4,000 common shares valued at $269,140 via Fidelity on the NYSE. Acquisition records show these shares originated from restricted stock vesting in early 2023 and were paid as compensation. Relative to the 128,525,470 shares outstanding, the position is negligible and unlikely to affect supply-demand dynamics or valuation. Absence of any reported sales in the prior three months and the explicit representation about undisclosed material information support compliance with Rule 144 disclosure expectations.
TL;DR: Filing meets disclosure norms; the sale is small and documented, reducing governance concerns.
The notice documents the broker (Fidelity Brokerage Services LLC), acquisition dates, and payment nature (compensation), which are key governance details for insider transactions. The filer states there is no material undisclosed information and reports no other sales in the past three months. Given the limited scale (4,000 shares) versus total outstanding shares, there is no evident governance red flag or material shareholder dilution from this transaction.